![](/img/cover-not-exists.png)
Comment on “Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results” by J.-M. Nabholtz et al.
H.T. Mouridsen, H.A. Chaudri-RossVolume:
40
Year:
2004
Language:
english
Pages:
1097
DOI:
10.1016/j.ejca.2003.09.040
File:
PDF, 100 KB
english, 2004